Trials / Completed
CompletedNCT05551182
Nicergoline Use in Dysphagia Patients
The Study of Efficacy on Low Dose Nicergoline in Dysphagia Patients Compares With High Dose Nicergoline.
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 92 (actual)
- Sponsor
- Phramongkutklao College of Medicine and Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
Dysphagia is a complication in patient with stroke, Parkinson's disease or dementia that can lead to aspiration pneumonia. This study aimed to investigate dysphagia improvement after treatment with nicergoline low dose and high dose, the relationship between nicergoline dose and clinical improvements, side effect of nicergoline and simulation optimal nicergoline dose in dysphagia improvement.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicergoline | The participants in both arms will receive nicergoline for treatment dysphagia 12 weeks. |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2025-07-31
- Completion
- 2025-08-20
- First posted
- 2022-09-22
- Last updated
- 2026-03-04
Locations
1 site across 1 country: Thailand
Source: ClinicalTrials.gov record NCT05551182. Inclusion in this directory is not an endorsement.